Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36 N.5, and our video podcast, CANCER BUZZ TV.
Biomarkers: A Roadmap for Personalized Lung Cancer Care, Live Panel, November 1 7pm ET



In This Section

Home / Learn / Cancer Types / Lung Cancer

Lung Cancer

Lung cancer is the second most diagnosed and the leading cause of cancer-related death, claiming nearly 1.8 million lives1 worldwide in 2020. By mid-2021, an estimated 235,760 new cases and 131,880 deaths from lung cancer have been reported in the United States.2

There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC, a slowly progressing lung cancer with few-to-no symptoms well into the advanced stage, accounts for 80 to 85% of patient diagnoses.3 SCLC, a rapidly growing and spreading cancer, accounts for 10-15% of all lung cancer diagnoses.3

While fragmentation of the healthcare system can impede consistent access to equitable care, gaps in the quality of cancer care delivery persist among certain patient populations due to prevailing social determinants of health4 and contribute to suboptimal outcomes.5-6


Defining Quality Care

ACCC has designed a quality benchmark to define ideal care for patients with stages III and IV non-small cell lung cancer, with an emphasis on leveraging the expertise of the multidisciplinary cancer team.
Explore Quality NSCLC Recommendations

“We have a paradox that with all the advances in research… there is a major gap in applying them to care. The nature of the multidisciplinary team is important and lung cancer is not just the realm of medical oncology—it's the realm of many different disciplines. Our emphasis in this work is uniting the different pieces of lung cancer care… [to find] the best way to care for patients.

David SpiegelDavid Spigel, MD,
Chief Scientific Officer; Director, Lung Cancer Research Program, Tennessee Oncology; Principal Investigator, Sarah Cannon Research Instituteend-quote

Explore this program:

Infographics & Video Summaries

Access new recommendations for defining high-quality care for this patient population through scientific presentations, infographics, and video summaries—broken down by multidisciplinary care team focus.

NSCLC Resource Library

Explore this robust resource bank of curated nationally-available materials to support your NSCLC patients. Filter by target audience (your clinical care team or your patients), cancer stage, or by keyword.

Improving Care Coordination

In order to identify and reduce barriers to care experienced by lung cancer patients covered by Medicaid, ACCC created a model framework to help cancer programs evaluate their current state of care coordination and identify areas of improvement. Assess Your Cancer Program

“The care coordination tool that ACCC developed [the Model] really helped us formally evaluate our program. We knew that patients diagnosed with lung cancer were getting lost in our system. We had a lot of late-stage lung cancer patients, and we needed to improve our case planning so we could identify those patients sooner."

sherri costa (1)Sherri Costa, MS, RN, AOCNS,
Manager of Cancer Support Services & Quality Improvement Coordinator, Ascension Wheaton Memorial Medical Centerend-quote

Explore this program:

6 Steps to Improve Care Coordination
See how this free, interactive online tool can help evaluate the current state of care coordination for lung cancer patients at your cancer program or practice, and identify focus areas for improvement and next steps.

Access Full Report
To leverage assessment results for the development of quality improvement projects, the Full Report is an ideal starting place. Its 12 Assessment Areas map to more than 100 quality measures for collecting and reporting data.

Upcoming Webinars and Events


Optimizing Advanced NSCLC Biomarker Testing, Treatment, and Management
This enduring material was recorded from an interactive, virtual (live) summit to enhance coordination of patient care and gain deeper scientific knowledge, skills, and competence in biomarker testing practices, treatment selection, and management of adverse events in patients with advanced NSCLC. This activity offers up to 4.5 hours of CME/CMLE credit.

Digital Tools

Biomarker Testing Implementation Roadmap for Advanced NSCLC
An innovative tool to implement, expand, and sustain biomarker testing for patients with advanced NSCLC.

Biomarker Testing Resource Library
Curated materials to support the implementation of biomarker testing for patients with advanced NSCLC.

Member Spotlight

Read how these ACCC Cancer Program Members have developed innovative programs to provide efficient, quality care to their patients with lung cancer.


Featured Opportunity

Best Practices in Early Stage NSCLC
This project will promote online collaborations among clinicians involved in the care of patients with early-stage NSCLC. The digital curriculum will incorporate real-time activities; collaborative, small group discussions and tasks; self-study modules; and a social learning platform. ACCC is currently recruiting Group Leaders (3-4 hours time over 8 weeks; honorarium provided) and Group Participants (2.5 hours time over 8 weeks).

Cancer Buzz Podcasts

Oncology Issues Articles

  •  Improving the Tumor Board Experience: Collaborative Technology Streamlines Multidisciplinary Conference Coordination
    Chryl Corizzo, RN
    In 2018, as St. Tammany Cancer Center worked to continue its American College of Surgeons Commission on Cancer (CoC) accreditation, the cancer center was hosting five monthly conferences: biweekly breast, lung, gastrointestinal conferences, and a general conference.
  •  Cancer Crushing Prevention and Early Detection
    By Chuck DeGooyer
    In looking at cancer incidence data, Tri-Cities Cancer Center found that its region was experiencing a higher rate of late-stage lung and colorectal diagnoses than the national average. The cancer center developed a creative and humorous marketing campaign and workplace wellness program to raise awareness and increase screening compliance.
  •  Robotic Bronchoscopy
    Amy Hindman
    Early identification, staging, and diagnosis of lung cancer is critical to improving patient outcomes. However, current diagnostic options are limited in accuracy, safety, and invasiveness—only 15 percent of patients with lung cancer are diagnosed at an early stage. Read how Fox Chase Cancer Center has implemented new flexible robotic endoscopic technology to diagnose hard-to-reach lung nodules with greater precision than ever before.
  •  A Small, Island Community Hospital Removes Barriers to Lung Cancer Screening and Detection
    By Donna Delfera, RN; Micayla Albers; Lysle Ailstock, MD; and Charles Shelton, MD
    Because of its growing retirement-age population and its unique location on a barrier island, The Outer Banks Hospital saw patients with lung cancer presenting at too late a stage for curative treatment. Learn how the hospital created an LDCT program and partnered with local providers and community cancer centers to identify patients with lung cancer at an earlier stage.
  •  Wheels Up: Bringing Lung Cancer Education and Screening to Rural Patients
    Derek Raghavan, MD, PhD, FACP, FRACP, FASCO; Mellisa Wheeler, BSW, MHA; Darcy Doege, RN, BSN; and Jen Tota McGivney, MA
    Lung cancer screenings are more effective and more affordable than ever before, but patient access still poses significant hurdles. Read how Levine Cancer Institute’s mobile lung LDCT unit brings lung screenings to underserved communities.
  •  How Lean Methodology can Improve Molecular Testing Processes in Advanced NSCLC
    Lawrence D. Wagman, MD, FACS; Raymond Casciari, MD; John Maurice, MD; Peggy J. Crabtree, MBA, RN; and Ruslan Horblyuk, PhD, MBA
    To see how lean methodology could be used to evaluate current molecular testing processes, identify waste, and design an improved process for advanced non-small cell lung cancer (NSCLC) in the community setting, a pilot study was conducted at St. Joseph Hospital, Orange, Center for Cancer Prevention and Treatment (SJH), located in Orange County, Calif.
  •  Development & Evolution of an Incidental Lung Lesion Program
    Esther Muscari Desimini, RN, MSN, BC, APRN; Patricia Aldredge, RN, MSN, ANP-BC; and Kimberly Gardner, RN, MSN, ACNP-BC
    Unexpected radiologic findings in the lungs (incidental lung lesions) on a diagnostic CT pose a risk of lack of follow-up and follow through for patients.



  1. Cancer. World Health Organization. Updated March 3, 2021. Accessed July 7, 2021. https://www.who.int/news-room/fact-sheets/detail/cancer
  2. Cancer Facts & Figures 2021. American Cancer Society. Updated 2021. Accessed July 7, 2021. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf
  3. What Is Lung Cancer? American Cancer Society. Updated October 2019. Accessed July 7, 2021. https://www.cancer.org/cancer/lung-cancer/about/what-is.html
  4. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Institute of Medicine. Published September 10, 2013. Accessed July 7, 2021. https://www.nap.edu/catalog/18359/delivering-high-quality-cancer-care-charting-a-new-course-for
  5. Slatore CG, Au DH, Gould MK. An Official American Thoracic Society Systematic Review: Insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med. 2010;182(9):1195-1205.
  6. Pezzi TA, Schwartz DL, Pisters KM, et al. Association of Medicaid insurance with survival among patients with small cell lung cancer. JAMA Netw Open. 2020;3(4):e203277

In the News